Stocks · Health care · Pharmaceutical Preparations

CORCEPT THERAPEUTICS INC

CORT Clue Score67
United States Fiscal year ends December CIK 0001088856 Results filed 3 Nov 2026

What the insiders did Scheduled selling only

By person

14 insiders · 8 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Sean Maduck
See Remarks
—
$2.05M (3) scheduled
−$2.05M
52,938
0.0490%
$4.38M
+38.0%
James N Wilson
Director
—
$1.15M (3) scheduled
−$1.15M
2,529,086
2.34%
$209.09M
−23.1%
Roberto Wandenkolk Vieira
President, Oncology
—
$674.07K (2) scheduled
−$674.07K
3,946
0.0037%
$326.24K
−3.0%
Joseph K Belanoff
Chief Executive Officer
—
—
—
2,565,489
2.37%
$212.10M
−5.8%
G Leonard Baker Jr
Director
—
—
—
2,241,893
2.07%
$185.35M
+12.0%
David L Mahoney
Director
—
—
—
1,133,539
1.05%
$93.72M
−8.0%
Hazel Hunt
Chief Scientific Officer
—
—
—
255,437
0.2363%
$21.12M
+115.4%
Gary Charles Robb
Chief Business Officer
—
—
—
114,059
0.1055%
$9.43M
+86.2%
Atabak Mokari
Chief Financial Officer
—
—
—
16,304
0.0151%
$1.35M
+30.2%
Joseph Douglas Lyon
See Remarks
—
—
—
5,683
0.0053%
$469.85K
−42.6%
William Guyer
Chief Development Officer
—
—
—
4,313
0.0040%
$356.58K
−25.6%
Daniel N Swisher JR
Director
—
—
—
0
0.0000%
$0.00
—
Kimberly Park
Director
—
—
—
0
0.0000%
$0.00
—
Gillian Cannon
Director
—
—
—
0
0.0000%
$0.00
—